Temi logo

Temi Review

7.8
★★★★☆3.9/5

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10

Best for: comparing partner pharmacies' compounded GLP-1 prices upfront, with no subscription

Price is where Temi scores best in our breakdown.

Semaglutide

$99per 4 weeks

Tirzepatide

$144per 4 weeks
Price rises with dose

What the monthly price covers

Medication

Not disclosed

Provider visits

Not disclosed

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Temi is an online prescription service from Self Systems, Inc. that lets you compare partner pharmacies' prices for compounded semaglutide and tirzepatide before a physician reviews your request. You pay the pharmacy's vial price plus a $39 prescription service per order, with no subscription. In California, a 28-day semaglutide vial order starts at $98.99 and tirzepatide at $143.99. It is available in 13 states.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedSemaglutideTirzepatideOral OptionLegitScript VerifiedNames its pharmacyNo subscriptionPhone Support Any Hour

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to Temi

7.7/ 10
Verified partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Verified partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Verified partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
“starting at” price
$129/motirzepatide
“starting at” price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
Temi logo
3.9 / 5
Our editorial rating
Visit Temi →

from $99/4 wks (billed per 4 weeks) · no insurance needed

Temi at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$99/4 wks (billed per 4 weeks)
Pricing model
Scales with dose: higher doses cost more
What's included
Shipping
Availability
13 states
FDA status
No FDA warning letter on record

How we scored Temi

Each dimension is scored algorithmically from Temi’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

9.0/10

At $99/mo (per 4 weeks), Temi runs about 46% below the $185 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Note the price scales with dose, so budget for higher tiers as you titrate.

Effectiveness25%

8.4/10

Temi offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions. An oral/needle-free option is offered for patients who avoid injections.

User Experience15%

7.1/10

Online intake and platform experience; 8 platform features disclosed.

Trust & Safety15%

8.0/10

Key details fully confirmed by our editors; no FDA warning letters on file.

Accessibility10%

6.4/10

Temi is available in 13 states. Confirm yours is covered.

Support10%

5.8/10

Temi provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
669providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this Temi review

Last checked November 2026
  • Confirmed current pricing across 7 dose/plan tiers
  • Confirmed availability in 13 states
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.

What we checked

Provider's own pricing page
$99–$299/mo across 7 dose/plan tiers (checked November 2026)
State pharmacy licensing & LegitScript status
LegitScript Verified
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with Temi

We walked Temi’s public signup flow in November 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1'See if you qualify' opens a short GLP-1 start: pick semaglutide, tirzepatide or 'I'm not sure', then a two-question quiz that starts with whether you've taken a GLP-1 before
  2. 2On a medication page you choose a weekly strength and your state, then compare partner pharmacies' vial prices
  3. 3The order summary shows the vial price, the $39 prescription service and the total authorization before checkout
  4. 4Temi says you then answer health questions, your card is held rather than charged, and a licensed physician reviews the request within 48 hours
Price shown before you start
  • Every compounded option names its pharmacy and shows the price per vial and per mg before you sign up
  • The card hold is charged when the physician decides; if the physician declines, only the $39 review fee is charged
  • For some GLP-1 orders, Temi's care team finishes the health questions with you by phone before the physician reviews
  • Temi's care team includes an AI assistant for routine questions; Temi says a physician makes every prescribing decision

Temi customer support

Phone
(855) 554-3030
Email
support@usetemi.com
Hours
Phone and text 24/7; messages usually answered within 48 hours

GLP-1 medications Temi offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

SemaglutideTirzepatideZepboundFoundayo

Pricing

Prices re-verified

28-day vial order at 0.2 to 1.5 mg a week, $39 prescription service included, no subscriptionCompounded
$98.99per 4 weeks
semaglutide

$59.99 for a 7.5 mg vial plus the $39 prescription service = $98.99 total authorization. Price shown for California at the lowest-priced partner pharmacy (Scripts Rx); vial prices vary by pharmacy, state and dose. Each vial is a 28-day supply after first use. No subscription: each order is its own request.

28-day vial order at 2 to 2.7 mg a week, $39 prescription service included, no subscriptionCompounded
$128.99per 4 weeks
semaglutide

$89.99 for a 12.5 mg vial plus the $39 prescription service = $128.99 total authorization. Price shown for California at the lowest-priced partner pharmacy (Scripts Rx); vial prices vary by pharmacy, state and dose. Each vial is a 28-day supply after first use. No subscription: each order is its own request.

28-day vial order at the 2 mg starting dose, $39 prescription service included, no subscriptionCompounded
$143.99per 4 weeks
tirzepatide

$104.99 for an 8.5 mg vial plus the $39 prescription service = $143.99 total authorization. Price shown for California at the lowest-priced partner pharmacy (Scripts Rx); vial prices vary by pharmacy, state and dose. Each vial is a 28-day supply after first use. No subscription: each order is its own request.

28-day vial order at 8.5 mg a week, $39 prescription service included, no subscriptionCompounded
$178.99per 4 weeks
tirzepatide

$139.99 for a 34 mg vial plus the $39 prescription service = $178.99 total authorization. Price shown for California at the lowest-priced partner pharmacy (Scripts Rx); vial prices vary by pharmacy, state and dose. Each vial is a 28-day supply after first use. No subscription: each order is its own request.

28-day vial order at 16.6 mg a week (top listed dose), $39 prescription service included, no subscriptionCompounded
$198.99per 4 weeks
tirzepatide

$159.99 for a 68 mg vial plus the $39 prescription service = $198.99 total authorization. Price shown for California at the lowest-priced partner pharmacy (Scripts Rx); vial prices vary by pharmacy, state and dose. Each vial is a 28-day supply after first use. No subscription: each order is its own request.

Zepbound 2.5 mg, LillyDirect self-pay price paid to LillyDirect (Temi's fee is separate)Brand-name
$299/mo
tirzepatide

Temi lists Lilly's self-pay prices: $299/mo at 2.5 mg, $399 at 5 mg, $449 at 7.5 to 15 mg. 'Temi does not sell or dispense it.'

Foundayo 0.8 mg daily, 30-day supply, LillyDirect price paid to LillyDirect (Temi's fee is separate)Brand-name
$149/mo
orforglipron

'$149 per 0.8 mg daily tablet (30-day supply)' via LillyDirect; 'Temi does not fill Foundayo through checkout.'

Ready to get started?

Plans and promotions change often, so check Temi's current pricing and active discounts before you decide.

See Temi pricing →

What we like

  • Shows each partner pharmacy's vial price and the total you'll be charged before you start
  • Low compounded prices: semaglutide from $98.99 and tirzepatide from $143.99 per 28-day vial order in California
  • No subscription or membership needed; each order is a separate request
  • Names the pharmacy on every option, such as Scripts Rx, Belmar and Red Rock
  • Phone and text support at any hour, plus email
  • LegitScript seal served from LegitScript's own site
  • Your card is held, not charged, until a physician decides; if the request is closed before any review, the hold is released

Watch-outs

  • Available in only 13 states
  • Prices rise with dose and vary by state and pharmacy, so your cost can differ from the starting figure
  • The $39 review fee is kept if the physician declines to prescribe
  • Medication is final sale once the order is sent to the pharmacy
  • The medical group that treats you depends on your state and isn't named on the site
  • Brand-name Zepbound and Foundayo are filled by LillyDirect, not through Temi's checkout
  • Disputes go to binding individual arbitration unless you opt out within 30 days

Is Temi worth it?

Temi's whole pitch comes down to this: comparing partner pharmacies' compounded GLP-1 prices upfront, with no subscription. It runs $98.99/month (per 4 weeks); there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. Its standout is a needle-free oral option for people who would rather not inject.

Beyond the medication itself, Temi is LegitScript-certified. It also names the pharmacy that fills its prescriptions and doesn't lock you into a subscription.

How much Temi costs

  • Compounded semaglutide runs $98.99–$128.99/month depending on plan, the low end listed as “per 4 weeks”, for that option.
  • Compounded tirzepatide runs $143.99–$198.99/month depending on plan, the low end listed as “per 4 weeks”, if you go that route.
  • Brand-name tirzepatide runs $299/month (rises with dose), at that tier.
  • Brand-name orforglipron runs $149/month (rises with dose), for that option.

Because Temi's headline figure is listed as “per 4 weeks”, we don't set it against the roughly $185 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Temi with the month-to-month prices of the alternatives below instead.

Eden (about $99/month) is one of the closest alternatives to weigh Temi against.

Medications: what Temi prescribes

Temi prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. Both routes are on the table: FDA-approved brand pens, or the cheaper compounded version that keeps the monthly cost down but isn't FDA-approved as a finished product.

Temi's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.

Who Temi is best for, and who should skip it

A good fit if you…

  • are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.

Look elsewhere if you…

  • need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.

Trust, safety, and medical oversight

Temi is available in 13 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.

Bottom line

Temi is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.

The Bottom Line

Price is where Temi scores best in our breakdown.

Score: 7.8/10Best for: comparing partner pharmacies' compounded GLP-1 prices upfront, with no subscriptionFrom: $99/4 wks (billed per 4 weeks)

Ready to start with Temi?

From $99/4 wks (billed per 4 weeks). See current pricing and start your free consultation.

Visit Temi →

Temi might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want built-in coaching and behavior-change support, consider Ro.
  • If you live outside its coverage area and need nationwide access, consider CoreAge Rx.
See all alternatives to Temi →

Head-to-head

Compare Temi vs…

Temi scores7.8/10

Side-by-side pricing, medications and scores. Pick a matchup.

Scores are our independent editorial ratings out of 10.

Frequently Asked Questions

Temi is an online prescription service from Self Systems, Inc. that lets you compare partner pharmacies' prices for compounded semaglutide and tirzepatide before a physician reviews your request. You pay the pharmacy's vial price plus a $39 prescription service per order, with no subscription. In California, a 28-day semaglutide vial order starts at $98.99 and tirzepatide at $143.99. It is available in 13 states. We scored it 7.8/10 across our six-dimension editorial framework.
Yes. Temi is a legitimate telehealth provider. Our editors independently verified its pricing and offering and scored it 7.8/10 across our six-dimension framework. As with any medication, consult a licensed clinician before starting.
Temi starts at $98.99/month (per 4 weeks). Pricing scales with your dose, so higher doses cost more. See the pricing table above for every tier.
Temi doesn't use public promo or coupon codes. Third-party sites advertising "Temi discount codes" are typically fake; any current offer applies automatically through the link on this page.
Temi is available in 13 states. Confirm your state is covered when you start your consultation.
Temi offers semaglutide (the active drug in Wegovy/Ozempic) and tirzepatide (the active drug in Zepbound/Mounjaro). You can choose FDA-approved brand-name or lower-cost compounded versions. A needle-free oral option is also available.
Temi offers both. Compounded semaglutide/tirzepatide from a licensed pharmacy is the lower-cost path; FDA-approved brand-name pens cost more but are the reference products. We explain the trade-offs in the review above.
Temi is a cash-pay program. No insurance is required, which is why the monthly price is transparent up front.
Temi's price includes shipping. See the "what's included" strip near the top of this review.
You complete an online intake, a licensed clinician looks at whether a GLP-1 fits your situation, and, if you're approved, your medication ships to your door. You can begin the consultation directly on Temi's site.
We don't find any safety warnings on file (no FDA action). The concerns our review flags are mostly transparency-related: Available in only 13 states; Prices rise with dose and vary by state and pharmacy, so your cost can differ from the starting figure; The $39 review fee is kept if the physician declines to prescribe; Medication is final sale once the order is sent to the pharmacy. None are safety issues, but they're worth weighing before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this Temi review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See Temi's current pricing

Plans from $99/4 wks (billed per 4 weeks). Start your free consultation to check eligibility and today's price.

Visit Temi →